The effects of cancer on the prostate can be seen very clearly in a ultrasound. (Ultrasounds are often used to guide biopsies.) The prostate is a critical gland in the male reproductive system that is prone to cancer development. When this happens, cells in the prostate start to mutate and then spread. During the latest stages of this cancer, the cells metastasize or spread from the prostate to other organs, glands, and body tissues. Prostate cancer is particularly prone to spreading to the lymph nodes and the skeletal system.
Benign prostatic hypertrophy and prostate adenoma are unrelated to prostate cancer, which is almost always a case of adenocarcinoma. Common symptoms of prostate cancer include difficulty urinating, pain, and erectile dysfunction. The condition responds to a range of different treatments, e.g. radiotherapy, surgery, chemotherapy, hormone therapy, or a combination of treatment approaches. There are other products available on the market that can help to reduce the effects of certain prostate conditions. Prosvent and Super Beta Prostate are two of such products that are helpful in reducing symptoms. Due diligence and online research will help you to uncover prosvent reviews, case studies, results and testimonials in order to help you make a sensible purchase decision.
Prostate cancer is most frequently found in men who are over 50 years of age. It’s the most common form of cancer found in men, and it causes more deaths than any other form except lung cancer. Many men develop early-stage prostate cancer symptoms but die due to unrelated causes before their cancer can be treated. A number of different factors can influence a man’s odds of developing prostate cancer; these include exposure to toxins, dietary habits, and genetics.
Breast cancer is found at differing rates in different parts of the world. It’s more common in Europe and the United States and less common in Southern and Eastern Asia. The American Cancer Society notes that breast cancer is frequently seen among patients of African descent and much rarer among those of Asian descent. (Note that breast cancer frequency may be influenced from region to region by differing prioritization of screening and detection.)
Cancer cells of some form are found in 30 to 70 percent of deceased men between the ages of 70 and 80 when they are autopsied. Prostate cancer is frequently asymptomatic. Only 10 percent of 50-year-old men with prostate cancer actually receive a positive diagnosis. Fatality rates for prostate cancer are roughly three percent.
Prostate Cancer Biology
The incidence of prostate cancer differs widely by region and family history. Black men – especially those with a genetic predisposition to prostate cancer – are particularly at risk. Statistics show that during the period between 1983 and 2002, prostate and stomach cancer deaths were twice as common in the Caribbean as they were in mainland North America. (The same data shows that lung and colorectal cancer were far less common in the same population.) This information points towards a combination of genetic and environmental factors that influence the frequency of prostate cancer. The disease is especially rare in Japan, for example, where the traditional diet includes soybeans, green tea, and other foods rich in selenium.
Causes of Prostate Cancer
It is still difficult to categorically define a cause for prostate cancer.
As noted above, genetics and heredity definitely play a role. Genetic studies indicate that there is a chromosome eight mutation that might be linked to the higher number of prostate cancer cases found in patients of African descent.
Among environmental factors, diets rich in lycopene and regular exercise appear to reduce the risk of prostate cancer while tobacco use increases it.
Detection Of Prostate Cancer
Prostate cancer is frequently found more or less by accident when healthcare providers are addressing other issues. Blood tests usually uncover the first signs of prostate cancer.
Blood tests can show the level of PSA in the blood. PSA, or prostate-specific antigen, is a protein that all prostate cells secrete. Cancerous cells release PSA at a rate 10 times greater than healthy cells. While this does show some promise as a simple method for detecting prostate cancer, there is a host of other conditions which might elevate a patient’s blood PSA levels. Infections, prostate volume, inflammation, and treatments for benign prostate issues might all increase PSA production. Although there is some question about moderate PSA levels, those above 10 ng / ml are clearly significant. More accurate measures to examine include PSA levels compared to prostate weight, the ratio of free PSA to total PSA, or long-term kinetic growth rates. Despite its ambiguity, PSA levels are still crucial to screening for and treating prostate cancer